Immunity Patterns of Covid-19 Recovered Patients in Gilgit Baltistan, Pakistan | [Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences • 2024]

Author(s):

1. Huda Khan: Department of Animal Sciences, Karakorum International University,Gilgit Baltistan,Pakistan

2. Maisoor Ahmed Nafees: Department of Animal Sciences, Karakorum International University,Gilgit Baltistan,Pakistan

3. Saif Ud Din: Department of Animal Sciences, Karakorum International University,Gilgit Baltistan,Pakistan

4. Mehran Kausar: Department of Animal Sciences, Karakorum International University,Gilgit Baltistan,Pakistan

5. Raja Imran: Department of Animal Sciences, Karakorum International University,Gilgit Baltistan,Pakistan

Abstract:

The main purpose of this study was to assess the immunity of recovered patients in COVID-19 patients. The idea was to unveil the nexus between the onset of COVID-19 coupled with the virulence of the disease and the immune responses of the target population in tandem with the intake of local/traditional foods. In the current study antibody presence and complete blood profile of 100 individuals were studied for COVID-19, from the Gilgit area. Immunity against COVID-19 recovered patients was observed during this investigation after more than eight months of their recovery. In this study, 78.2% of people were positive for Immunoglobin G antibody and 23.7% for Immunoglobin M antibody. The most infected age group recorded was 31-40 years. The mean blood glucose level in random was 143.38 mg/dL and 128.18 mg/dL in males and females, respectively. The mean cholesterol level in males was 148.82 mg/dL while the female cholesterol mean was 126.49 mg/dL. White Blood Cells were observed within their prescribed ranges. The mean hemoglobin level was 14.580 g/dL and 12.022 g/dL while mean RBC was 4.7838×106 m/µL and 4.2993×106 m/µL and the mean platelets were 238.45×103/µL and 261.91×103/µL in male and female, respectively. It is observed that the A+ blood group was more susceptible to infection. About 75% of individuals consume highly rich and nutritious food. About 55% of people engaged themselves with exercise. 25% of participants used their normal regular diet during the infection phase on the other hand 75% of individuals treated themselves with a specific and highly nutritious diet for their rapid and healthy recovery. More than 65% of people were re-infected after COVID-19 vaccination but the symptoms were not severe. Due to the strong innate immunity of people from this region, they recovered more rapidly. The dietary habits, high hemoglobin levels coupled with regular exercise might have a positive impact on early recovery of COVID-19-infected patients.

Page(s): 35-46

DOI: 10.53560/PPASB(61-1)818

Published: Journal: Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, Volume: 61, Issue: 1, Year: 2024

Keywords:

immunity , susceptibility , IgG , vaccination , IgM

References:

[1] Wu Y.,Feng Z.,Li P.,Yu and Q. .2020 .Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clinica Chimica Acta, 509 : 220-223.

[2] D.D. Richman R.J.,Whitley F.G. .2016 .. Clinical virology Fourth Edition. ASM Books, : .

[3] Hoek L.V.D. .2007 .Human coronaviruses: What do they cause?. Antiviral Therapy, 12 : 651-658.

[4] Pene F.,Merlat A.,Vabret A.,Rozenberg F.,Buzyn A.,Dreyfus F.,Cariou A.,Freymuth F.,Lebon. Coronavirus P. .2003 .-Related Pneumonia in Immunocompromised Patients. Clinical Infectious Diseases, 37 : 929-932.

[5] Walsh E.E.,Shin J.H.,Falsey A.R. .2013 .Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. The Journal of Infectious Diseases, 208(10) : 1634-1642.

[6] Gorse G.J.,T.Z. O'Connor S.L.,Hall J.N.,Vitale K.L.,Nichol K.L. .2009 .Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease. The Journal of Infectious Diseases, 199 : 847-857.

[7] Gralinski L.E.,Menachery V.D. .2020 .. Return of the Coronavirus: 2019-nCoV. Viruses, 135(2) : .

[8] Tan W.,Zhao X.,X X.,Niu P.,Xu W.,Wu G. .2020 .China CDC weekly 2(4. , : 61-62.

[9] Zhu N.,Zhang D.,Wang W.,Li X.,Yang B.,Song J.,Zhao X.,Huang B.,Shi W.,Lu R.,Niu P.,Zhan F.,Ma X.,Wang D.,Xu W.,Gao G. F.,Tan W. .2020 .A novel coronavirus from patients with pneumonia in China. The New England Journal of Medicine, 382 : 727-33.

[10] .2020 .-advice-for-adults-duringthe-covid-19-outbreak. , : .

[11] Azar .2020 .Control Applications for Biomedical Engineering Systems. , : .

[12] Brauer F.,Castillo-Chavez C. .2010 .. Mathematical models in population biology and epidemiology, : .

[13] Li Q.,Guan X.,Wu P.,Wang X.,Zhou L.,Tong Y.,Feng Z. .2020 .Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 382(13) : 1199-1207.

[14] Ong S.W.X.,Tan Y.K.,Chia P.Y.,Lee T.H.,Ng O.T.,Wong M.S.Y.,Marimuthu K. .2020 .Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA, 323(16) : 1610-1612.

[15] Guan W.H.,Liang Y.,Zhao H.R.,Liang Z.S.,Chen Y.M.,Li and J.X.,He and J.X. .2020 .Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal, 2000547(5) : .

[16] Guan Z.Y.,Ni Y.,Hu W.H.,Liang C.Q.,Ou J.X.,He N.S. Zhong. .2020 .Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18) : 1708-1720.

[17] C. Sohrabi Z.,Alsafi N.,Khan M.,Kerwan A.,Al-Jabir A.,Agha R. .2020 .World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76 : 71-76.

[18] C. Huang Y.,Wang X.,Li L.,Ren J.,Zhao Y.,Hu L.,Zhang J.,Xu X.,Gu J.,Xia Y.,Wei W.,Wu X.,Xie W.,Yin H.,Li M.,Liu Y.,Xian H.,Gao L.,Guo J.,Xie G.,Wang R.,Jiang Z.,Gao Q.,Jin J.,Wangi B. Coat. .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 : 497-506.

[19] Hu Q.,Guan H.,Sun Z,Huang L.,Chen C.,Ai T.,Xia L. .2020 .Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China. European Journal of Radiology, 128 : 109017.

[20] Y.M. Arabi S,Murthy S.,Webb S. .2020 .a novel coronavirus and a novel challenge for critical care. Intensive Care Medicine, 46 : 833-36.

[21] Long Q.X.,Liu B.Z.,Deng H.J.,Wu G.C.,Deng K.,Chen Y.K.,Huang A.L. .2020 .Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine, 26(6) : 845-848.

[22] A.Z. Ahmad K.,Shahzad M.,Masood M.,Umar F.,Abbasi A.,Hafeez A. .2022 .COVID-19 seroprevalence in Pakistan: a cross-sectional study. BMJ Open, 12(4) : .

[23] Farah F.,Mehwish A.,Nafisa H.A. .2013 .Comparative Study in the Diagnosis of Anemia by SYSMEX KX21N hematology analyzer with Peripheral Blood Smear. International Journal of Endorsing Health Science, 1(2) : 89-92.

[24] Wang J. .2020 .Dynamic changes in routine blood parameters of a severe COVID-19 case. Clinica Chimica Acta, 508 : 98-102.

[25] Li H.,- H. .2020 .Attacks the 1-beta Chain of Hemoglobin and Captures the Porhyrin to Inhibit Heme Metabolism. СhemRxiv, 10 : .

[26] Lanini S.,Montaldo C.,Nicastri E.,Vairo F.,Agrati C.,Petrosillo N.,G. N. .2020 .Ippolito COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PloS One, 15(12) : .

[27] Xu P.,Zhou Q.,Xu J. .2020 .Mechanism of thrombocytopenia in COVID-19 patients. Annals of Hematology, 99(6) : 1205-1208.

[28] Plebani M.,Henry B.M. .2020 .Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica Chimica Acta, 506 : 145-148.

[29] Li M.,Dong Y.,Zhou H.,Zhang Z.,Tian C.,Hu D. .2020 .Diabetes is a risk factor for the progression. prognosis of COVID‐19. Diabetes/ Metabolism Research and Reviews, 36(7) : .

[30] Zhou F.,Yu T.,Du R.,Liu Y.,Liu Z.,B. Cao. Z. .2020 .Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229) : 1054-1062.

[31] Zaki N.,Alashwal H.,Ibrahim S. .2020 .Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes & Metabolic Syndrome, 14(5) : 1133-1142.

[32] Deng S.Q.,Peng H.J. .2020 .Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of Clinical Medicine, 575(2) : .

[33] Rezen T.,Rozman D. .2021 .Basic concepts and clinical applications. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 158849 : .

[34] Daniels A.M.,Sitapati J.,Zhang J.,Zou Q.M.,Bui J.,Ren K.,Messer K. .2020 .Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients. The American Journal of Cardiology, 136 : 149-155.

[35] Ho F.K.,Petermann-Rocha F.,Gray S.R.,Jani B.D.,Katikireddi S.V.,Niedzwiedz C.J.,Pell J.P. .2020 .Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One, 15(11) : .

[36] .2020 .Why are age and obesity risk factors for serious disease. BMJ, 371(m4130) : .

[37] Huynh A.,Arnold D.M.,Smith J.W.,Moore J.C.,Zhang A.,Chagla Z.,Harvey B.J.,Stacey H.D.,Ang J.C.,Clare R.,Ivetic N.,Chetty V.T.,Bowdish D.M.E.,Miller M.S.,Kelton J.G.,and I. Nazy. J.G. .2021 .Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects. Viruse, 697(4) : .

[38] Bitzogli K.,Magira E.,Chatzis L.,Alexopoulos H.,Dalakas M.,Vlachoyiannopoulos P. .2021 .AB0697 ANTI-SARS-COV-2 antibodies and autoantibodies in covid-19 patients survived after icu admission, 6 months later. Annals of the Rheumatic Diseases, 80 : 1381.

[39] J. Elslande M.,Oyaert S.,Ailliet S.,M. Van Ranst N.,Lorent Y.V.,Weygaerde P.,Vermeersch P. .2021 .Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. Journal of Clinical Virology, 136 : 104765.

[40] Ibarrondo F.J.,Fulcher J.A.,Goodman-Meza D.,Elliott J.,Hofmann C.,Hausner M.A.,Yang O.O. .2021 .Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild. Covid-19. The New England Journal of Medicine, 383(11) : 1085-1087.

[41] Adams E.R.,Ainsworth M.,Anand R.,Andersson M.I.,Auckland K.,Baillie J.K.,Barnes E.,Beer S.,Bell J.I.,Berry T.,Bibi S.,Carroll M.,Chinnakannan S.K.,Ploeg R.J.,Pollard A. .2020 .Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. Wellcome Open Research, 139(5) : .

[42] H.X. Gao Y.N.,Li Z.G.,Xu Y.L.,Wang H.B.,Wang J.F.,Cao E.H.,Dai E.H. .2020 .Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from diferent stages. China Medical Journal, 133 : 1479-1480.

[43] A.H. Alzaabi L.A.,Ahmed A.E.,Rabooy A.A.,Zaabi M,Alkaabi F.,AlMahmoud K.A.,Mazrouei K.A. .2021 .Longitudinal changes in IgG levels among COVID19 recovered patients: A prospective cohort study. PLoS One, 16(6) : .

[44] J.M. Jin P.,Bai W.,He F.,Wu X.F.,Liu D.M.,Han J.K.,Yang J.K. .2020 .Gender diferences in patients with COVID-19: focus on severity and mortality. Frontiers in Public Health, 8 : 152.

[45] Mauvais-Jarvis F. .2020 .Aging, male sex, obesity, and metabolic inflammation create the perfect storm for. COVID-19. Diabetes, 69(9) : 1857-1863.

[46] Araç S. .2021 .ABO blood groups in COVID‐19 patients; cross‐sectional study. International Journal of Clinical Practice, 75(4) : .

[47] Goker E.A.,Karakulak H.,Demiroğlu C.M.A.,Ceylan Y.,Büyükaşik A.C.,Inkaya S.,Ünal S. .2020 .The efects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turkish Journal of Medical Sciences, 679(4) : .

[48] Velavan T.P. .2020 .. The COVID‐19 epidemic. Tropical Medicine & International Health, 278(3) : .

[49] C. Qin L.,Zhou Z.,Hu S.,Zhang S.,Yang Y.,Tao C.,Xie K.,Ma K.,Shang W.,Wang D.S.,Tian D.S. .2020 .Dysregulation of immune response in patients with COVID-. China. Clinical Infectious Diseases, 71(15) : 762-768.

[50] Walsh N.P.,Gleeson M.,Shephard R.J.,Gleeson M.,Woods J.A.,Bishop N.,Simon P. .2011 .Position statement. part one: Immune function and exercise. Exercise Immunology Review, 17 : 6-63.

[51] J. Vina F.,Sanchis‐Gomar V.,Martinez‐Bello M.C.,Gomez‐Cabrera M.C. .2012 .Exercise acts as a drug; the pharmacological benefits of exercise. British Journal of Pharmacology, 167(1) : 1-12.

[52] Sallis R.,Young D.R.,Tartof S.Y.,Sallis J.F.,Sall J.,Li Q.,Cohen and D.A. .2021 .Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48440 adult patients. British Journal of Sports Medicine, 55(19) : 1099-1105.

[53] K.A.B. Davies S.,Pickles V.S.,Sprung G.J.,Kemp U.,Alam D.R.,Moore D.J.,Cuthbertson D.J. .2019 .Reduced physical activity in young and older adults: metabolic and musculoskeletal implications. Therapeutic Advances in Endocrinology and Metabolism, 10 : 1-15.

[54] Aman F.,Masood S. .2020 .How Nutrition can help to fight against COVID-19 Pandemic. Pakistan Journal of Medical Sciences, 36(COVID19) : S121-23.

[55] Afshin A.,Sur P.J.,Fay K.A.,Cornaby L.,Salama J.S.,Murray C.J. .2019 .a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 393(10184) : 1958-1972.

[56] Deutz N.E.,Bauer J.M.,Barazzoni R.,Boirie Y.,Bosy-Westphal A.,Calder P.C. .2014 .Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clinical Nutrition, 33(6) : 929-936.

[57] Prado-Vivar M.,Becerra-Wong J.J.,Guadalupe S.,Marquez B.,Gutierrez P.,Rojas-Silva P.,Cardenas. P.,Re- P. .2020 .Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America. SSRN, : .

[58] R.L. Tillett J.R.,Sevinsky P.D.,Hartley H.,Kerwin N.,Crawford A.,Gorzalski M.,Pandori M. .2021 .Genomic evidence for reinfection with SARSCoV-2: a case study. The Lancet Infectious Diseases, 21(1) : 52-58.

[59] Baud D.,Gengler C.,Jaton K.,Pomar L. .2020 .Second-trimester miscarriage in a pregnant woman with SARSCoV-2 infection. JAMA, 323(21) : 2198-2200.

[60] Wang X.,Zhou Z.,Zhang J.,Zhu F.,Tang Y.,Shen X. .2020 .A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clinical Infectious Diseases, 71(15) : 844-6.

[61] Schwartz D.A. .2020 .An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Archives of Pathology & Laboratory Medicine, 144(7) : 799-805.

[62] Zeng C.,Xu J.,Fan Y.,Tang Q.,Deng W.,Zhang X.,Long X. .2020 .Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA, 323(18) : 1848-49.

[63] Farhat A.S.,Sayedi S.J.,Akhlaghi F.,Hamedi A.,Ghodsi. A. .2020 .Coronavirus (COVID-19) infection in newborns. International Journal of Pediatrics, 8(6) : 11513-11517.

Citations

Downloads

Views